{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T06:24:03Z","timestamp":1787207043218,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Wolman disease is the severe infantile form of lysosomal acid lipase deficiency, caused by biallelic pathogenic variants in the Lysosomal Acid Lipase (LIPA) gene. It is rapidly progressive and often fatal within the first year of life without disease-specific therapy. Because early manifestations are non-specific, timely diagnosis remains challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the cases of two Chinese male infants with genetically confirmed Wolman disease. Case 1 involved an 8-week-old infant\u2014born to consanguineous parents\u2014who presented with persistent diarrhea, recurrent low-grade fever, abdominal distension, hepatosplenomegaly, ascites, bilateral adrenal involvement, anemia, thrombocytopenia, hypoproteinemia, dyslipidemia, coagulopathy, and electrolyte disturbances. Liver biopsy showed diffuse hepatocyte vacuolization. Genetic testing identified a novel homozygous LIPA variant\u2014c.285G\u2009&amp;gt;\u2009T\/p.Trp95Cys\u2014inherited from heterozygous carrier parents. Lysosomal acid lipase activity was markedly reduced to 0.62% of the normal control level. Case 2 involved an 11-week-old infant who presented with failure to thrive, poor feeding, abdominal distension, cough, progressive hepatosplenomegaly, ascites, bilateral adrenal calcifications, hepatic dysfunction, systemic inflammation, coagulopathy, anemia, and thrombocytopenia. He carried compound heterozygous LIPA non-sense variants, c.796G\u2009&amp;gt;\u2009T\/p.Gly266* and c. 193C\u2009&amp;gt;\u2009T\/p.Arg65*, inherited from his mother and father, respectively. Despite supportive care, both infants developed progressive multiorgan failure and died.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These cases expand the clinical and molecular spectrum of Wolman disease in Chinese infants and highlight important diagnostic challenges, including non-specific early manifestations and inflammatory presentations mimicking hematologic disorders. Recognition of the characteristic combination of hepatosplenomegaly, failure to thrive, dyslipidemia, adrenal calcification, reduced lysosomal acid lipase activity, and LIPA variants may facilitate early diagnosis. Timely identification is essential because early enzyme replacement therapy may alter the otherwise fatal natural course of this rapidly progressive disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1933873","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:29:11Z","timestamp":1787203751000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Wolman disease caused by LIPA variants in two Chinese infants and a focused literature synthesis"],"prefix":"10.3389","volume":"14","author":[{"given":"Leping","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Sijing Hospital of Songjiang District","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Inner Mongolia Maternal and Child Health Care Hospital","place":["Hohhot, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Sijing Hospital of Songjiang District","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbao","family":"Xie","sequence":"additional","affiliation":[{"name":"Pediatric Liver Center, Children\u2019s Hospital of Fudan University, National Children\u2019s Medical Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/2213988501711010001","article-title":"Targeting Wolman disease and cholesteryl ester storage disease: disease pathogenesis and therapeutic development","volume":"11","author":"Aguisanda","year":"2017","journal-title":"Curr Chem Genom Transl Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.3390\/nu16244309","article-title":"Practical recommendations for the diagnosis and management of lysosomal acid lipase deficiency with a focus on Wolman disease","volume":"16","author":"de Las Heras","year":"2024","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","article-title":"Wolman\u2019s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency","volume":"2","author":"Pericleous","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"429.e1","DOI":"10.1016\/j.medcle.2017.04.021","article-title":"Update on lysosomal acid lipase deficiency: diagnosis, treatment and patient management","volume":"148","author":"Camarena","year":"2017","journal-title":"Med Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/gim.2015.108","article-title":"Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants","volume":"18","author":"Jones","year":"2016","journal-title":"Genet Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13256-023-04116-4","article-title":"Wolman disease presenting with hemophagocytic lymphohistiocytosis syndrome and a novel Lipa gene variant: a case report and review of the literature","volume":"17","author":"Asna Ashari","year":"2023","journal-title":"J Med Case Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jped.2021.03.003","article-title":"Lysosomal acid lipase deficiency in pediatric patients: a scoping review","volume":"98","author":"Witeck","year":"2022","journal-title":"J Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12887-021-02541-2","article-title":"Wolman\u2019s disease presenting with secondary hemophagocytic lymphohistiocytosis: a case report from Saudi Arabia and literature review","volume":"21","author":"Alabbas","year":"2021","journal-title":"BMC Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/8904_2017_6","article-title":"Lysosomal acid lipase deficiency in 23 Spanish patients: high frequency of the novel C.966+2t>G mutation in Wolman disease","volume":"37","author":"Ruiz-Andr\u00e9s","year":"2017","journal-title":"JIMD Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/bmt.2008.273","article-title":"Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease","volume":"43","author":"Tolar","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00431-006-0298-6","article-title":"Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation","volume":"166","author":"Stein","year":"2007","journal-title":"Eur J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/sj.bmt.1702557","article-title":"Wolman disease successfully treated by bone marrow transplantation","volume":"26","author":"Krivit","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/bmt.2009.57","article-title":"Pathological evidence of Wolman\u2019s disease following hematopoietic stem cell transplantation despite correction of lysosomal acid lipase activity","volume":"44","author":"Gramatges","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/hep.26289","article-title":"Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease","volume":"58","author":"Balwani","year":"2013","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s13023-021-02134-3","article-title":"Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up","volume":"16","author":"Demaret","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13023-021-01849-7","article-title":"Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease","volume":"16","author":"Potter","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/08880018.2014.920942","article-title":"Wolman\u2019s disease with secondary hemophagocytic lymphohistiocytosis","volume":"31","author":"Rabah","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/jci116888","article-title":"A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease","volume":"92","author":"Klima","year":"1993","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/geno.1996.0162","article-title":"Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity","volume":"33","author":"Aslanidis","year":"1996","journal-title":"Genomics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0022-2275(20)39119-7","article-title":"A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred","volume":"37","author":"Ries","year":"1996","journal-title":"J Lipid Res"},{"key":"B23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/BF02436008","article-title":"Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease","volume":"18","author":"Maslen","year":"1995","journal-title":"J Inherit Metab Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"bcr2013202652","DOI":"10.1136\/bcr-2013-202652","article-title":"Infant case of lysosomal acid lipase deficiency: Wolman\u2019s disease","volume":"2014","author":"Sadhukhan","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/mgme.1999.2904","article-title":"Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease","volume":"68","author":"Anderson","year":"1999","journal-title":"Mol Genet Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1542\/peds.46.3.431","article-title":"Lipid studies in Wolman\u2019s disease","volume":"46","author":"Kyriakides","year":"1970","journal-title":"Pediatrics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molmed.2023.03.001","article-title":"Recent insights into lysosomal acid lipase deficiency","volume":"29","author":"Korbelius","year":"2023","journal-title":"Trends Mol Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1933873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:29:12Z","timestamp":1787203752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1933873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":27,"alternative-id":["10.3389\/fped.2026.1933873"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1933873","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1933873"}}